374 related articles for article (PubMed ID: 20302320)
1. Reaction rates and mechanism of the ascorbic acid oxidation by molecular oxygen facilitated by Cu(II)-containing amyloid-beta complexes and aggregates.
Jiang D; Li X; Liu L; Yagnik GB; Zhou F
J Phys Chem B; 2010 Apr; 114(14):4896-903. PubMed ID: 20302320
[TBL] [Abstract][Full Text] [Related]
2. Amyloid beta-Cu2+ complexes in both monomeric and fibrillar forms do not generate H2O2 catalytically but quench hydroxyl radicals.
Nadal RC; Rigby SE; Viles JH
Biochemistry; 2008 Nov; 47(44):11653-64. PubMed ID: 18847222
[TBL] [Abstract][Full Text] [Related]
3. Capturing a reactive state of amyloid aggregates: NMR-based characterization of copper-bound Alzheimer disease amyloid β-fibrils in a redox cycle.
Parthasarathy S; Yoo B; McElheny D; Tay W; Ishii Y
J Biol Chem; 2014 Apr; 289(14):9998-10010. PubMed ID: 24523414
[TBL] [Abstract][Full Text] [Related]
4. Redox reactions of copper complexes formed with different beta-amyloid peptides and their neuropathological [correction of neuropathalogical] relevance.
Jiang D; Men L; Wang J; Zhang Y; Chickenyen S; Wang Y; Zhou F
Biochemistry; 2007 Aug; 46(32):9270-82. PubMed ID: 17636872
[TBL] [Abstract][Full Text] [Related]
5. Specific Binding of Cu(II) Ions to Amyloid-Beta Peptides Bound to Aggregation-Inhibiting Molecules or SDS Micelles Creates Complexes that Generate Radical Oxygen Species.
Tiiman A; Luo J; Wallin C; Olsson L; Lindgren J; Jarvet J; Per R; Sholts SB; Rahimipour S; Abrahams JP; Karlström AE; Gräslund A; Wärmländer SK
J Alzheimers Dis; 2016 Oct; 54(3):971-982. PubMed ID: 27567855
[TBL] [Abstract][Full Text] [Related]
6. Identifying, by first-principles simulations, Cu[amyloid-β] species making Fenton-type reactions in Alzheimer's disease.
La Penna G; Hureau C; Andreussi O; Faller P
J Phys Chem B; 2013 Dec; 117(51):16455-67. PubMed ID: 24313818
[TBL] [Abstract][Full Text] [Related]
7. β-amyloid fibrils in Alzheimer disease are not inert when bound to copper ions but can degrade hydrogen peroxide and generate reactive oxygen species.
Mayes J; Tinker-Mill C; Kolosov O; Zhang H; Tabner BJ; Allsop D
J Biol Chem; 2014 Apr; 289(17):12052-12062. PubMed ID: 24619420
[TBL] [Abstract][Full Text] [Related]
8. Ternary complexes of iron, amyloid-beta, and nitrilotriacetic acid: binding affinities, redox properties, and relevance to iron-induced oxidative stress in Alzheimer's disease.
Jiang D; Li X; Williams R; Patel S; Men L; Wang Y; Zhou F
Biochemistry; 2009 Aug; 48(33):7939-47. PubMed ID: 19601593
[TBL] [Abstract][Full Text] [Related]
9. Methionine does not reduce Cu(II)-beta-amyloid!--rectification of the roles of methionine-35 and reducing agents in metal-centered oxidation chemistry of Cu(II)-beta-amyloid.
da Silva GF; Lykourinou V; Angerhofer A; Ming LJ
Biochim Biophys Acta; 2009 Jan; 1792(1):49-55. PubMed ID: 19061952
[TBL] [Abstract][Full Text] [Related]
10. An integrated study of the affinities of the Aβ16 peptide for Cu(I) and Cu(II): implications for the catalytic production of reactive oxygen species.
Young TR; Kirchner A; Wedd AG; Xiao Z
Metallomics; 2014 Mar; 6(3):505-17. PubMed ID: 24493126
[TBL] [Abstract][Full Text] [Related]
11. The redox chemistry of the Alzheimer's disease amyloid beta peptide.
Smith DG; Cappai R; Barnham KJ
Biochim Biophys Acta; 2007 Aug; 1768(8):1976-90. PubMed ID: 17433250
[TBL] [Abstract][Full Text] [Related]
12. Abeta40, either soluble or aggregated, is a remarkably potent antioxidant in cell-free oxidative systems.
Baruch-Suchodolsky R; Fischer B
Biochemistry; 2009 May; 48(20):4354-70. PubMed ID: 19320465
[TBL] [Abstract][Full Text] [Related]
13. Nucleoside-5'-phosphorothioate analogues are biocompatible antioxidants dissolving efficiently amyloid beta-metal ion aggregates.
Amir A; Shmuel E; Zagalsky R; Sayer AH; Nadel Y; Fischer B
Dalton Trans; 2012 Jul; 41(28):8539-49. PubMed ID: 22652964
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effect of human serum albumin on Cu-induced Aβ(40) aggregation and toxicity.
Lu N; Yang Q; Li J; Tian R; Peng YY
Eur J Pharmacol; 2015 Nov; 767():160-4. PubMed ID: 26463036
[TBL] [Abstract][Full Text] [Related]
15. X-ray Absorption Spectroscopy Investigations of Copper(II) Coordination in the Human Amyloid β Peptide.
Summers KL; Schilling KM; Roseman G; Markham KA; Dolgova NV; Kroll T; Sokaras D; Millhauser GL; Pickering IJ; George GN
Inorg Chem; 2019 May; 58(9):6294-6311. PubMed ID: 31013069
[TBL] [Abstract][Full Text] [Related]
16. Modeling copper binding to the amyloid-β peptide at different pH: toward a molecular mechanism for Cu reduction.
Furlan S; Hureau C; Faller P; La Penna G
J Phys Chem B; 2012 Oct; 116(39):11899-910. PubMed ID: 22974015
[TBL] [Abstract][Full Text] [Related]
17. Mechanistic Insight into the Design of Chemical Tools to Control Multiple Pathogenic Features in Alzheimer's Disease.
Han J; Du Z; Lim MH
Acc Chem Res; 2021 Oct; 54(20):3930-3940. PubMed ID: 34606227
[TBL] [Abstract][Full Text] [Related]
18. A comprehensive study on the generation of reactive oxygen species in Cu-Aβ-catalyzed redox processes.
Huang H; Lou X; Hu B; Zhou Z; Chen J; Tian Y
Free Radic Biol Med; 2019 May; 135():125-131. PubMed ID: 30849487
[TBL] [Abstract][Full Text] [Related]
19. Effect of metal chelators on the aggregation of beta-amyloid peptides in the presence of copper and iron.
Tahmasebinia F; Emadi S
Biometals; 2017 Apr; 30(2):285-293. PubMed ID: 28281098
[TBL] [Abstract][Full Text] [Related]
20. Heme-Cu bound aβ peptides: spectroscopic characterization, reactivity, and relevance to Alzheimer's disease.
Pramanik D; Ghosh C; Dey SG
J Am Chem Soc; 2011 Oct; 133(39):15545-52. PubMed ID: 21870836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
